Ngā hua rapu - Ambroos E.M. Reijs

  • E whakaatu ana i te 1 - 5 hua o te 5
Whakamahine hua
  1. 1
    Akinesis becoming dyskinesis during high-dose dobutamine stress echocardiography: A marker of myocardial ischemia or a mechanical phenomenon?

    Akinesis becoming dyskinesis during high-dose dobutamine stress echocardiography: A marker of myocardial ischemia or a mechanical phenomenon? mā Mariarosaria Arnese, P. Fioretti, Jan H. Cornel, Joyce Postma-Tjoa, Ambroos E.M. Reijs, Jos R.T.C. Roelandt

    I whakaputaina 1994
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Simultaneous dobutamine stress echocardiography and technetium-99m isonitrile single-photon emission computed tomography in patients with suspected coronary artery disease

    Simultaneous dobutamine stress echocardiography and technetium-99m isonitrile single-photon emission computed tomography in patients with suspected coronary artery disease mā Tamás Forster, Albert J. McNeill, Alessandro Salustri, Ambroos E.M. Reijs, El-Said M. El-Said, Jos R.T.C. Roelandt, P. Fioretti

    I whakaputaina 1993
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Prediction of recovery of myocardial dysfunction after revascularization comparison of fluorine-18 fluorodeoxyglucose/thallium-201 SPECT, thallium-201 stress-reinjection SPECT and dobutamine echocardiography

    Prediction of recovery of myocardial dysfunction after revascularization comparison of fluorine-18 fluorodeoxyglucose/thallium-201 SPECT, thallium-201 stress-reinjection SPECT and... mā J. J. Bax, Jan H. Cornel, Frans C. Visser, P. Fioretti, Arthur van Lingen, Ambroos E.M. Reijs, Eric Boersma, G. J. J. Teule, Cees A. Visser

    I whakaputaina 1996
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Radiotherapy with a Radiolabeled Somatostatin Analogue, [<sup>111</sup>In‐DTPA‐<scp>d</scp>‐Phe<sup>1</sup>]‐Octreotide

    Radiotherapy with a Radiolabeled Somatostatin Analogue, [<sup>111</sup>In‐DTPA‐<scp>d</scp>‐Phe<sup>1</sup>]‐Octreotide mā E. P. Krenning, P.P.M. Kooij, Willem H. Bakker, W A Breeman, P.T.E. Postema, Dik J. Kwekkeboom, H.Y. Oei, Marion de Jong, T. J. Visser, Ambroos E.M. Reijs, S. W. J. Lamberts

    I whakaputaina 1994
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients

    Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients mā E. P. Krenning, Dik J. Kwekkeboom, Willem H. Bakker, Wout A. P. Breeman, P.P.M. Kooij, H.Y. Oei, M. van Hagen, P.T.E. Postema, Marion de Jong, Jean Claude Reubi, T. J. Visser, Ambroos E.M. Reijs, Leo J. Hofland, Jan W. Koper, S. W. J. Lamberts

    I whakaputaina 1993
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: